DeGen Medical Receives Clearance of F1 MPS(TM) System for

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DeGen Medical Receives Clearance of F1 MPS(TM) System for JOUST(TM) Minimally Invasive Surgical Procedure

FLORENCE, S.C., July 26, 2016 (GLOBE NEWSWIRE) -- DeGen Medical has received clearance from the FDA for its F1 MPS™ Modular Pedicle Screw System for JOUST™ Minimally Invasive Surgery (MIS) procedure. The JOUST™ MIS is a modular pedicle screw with cobalt-chrome alloy head for percutaneous procedures.   The JOUST™ MIS technology includes MIS Towers for percutaneous screw placement, traditional or cortical approach, and rod reduction is built in the Tower. The unique Rod Insertion Tool with JOUST™ Minimally Invasive Rods aids in achieving a stable fusion construct without undergoing the traditional open approach. JOUST™ MIS procedure allows the surgeon to place the pedicle screws with minimal muscle stripping causing reduced muscle damage and lessening scar tissue formation from decreased dissection. The robust instrumentation allows for smooth implantation in a complex lumbar spine surgery over multiple levels.   The JOUST™ MIS technology with F1 MPS™ System will be available in Q4 of 2016.   About DeGen Medical, Inc. DeGen Medical, Inc. is a medical-device development company dedicated to providing surgeons with innovative products engineered to improve quality of life for patients with complex spinal disorders. World-class implants, coupled with intuitively-designed instrumentation, provide a complete package to promote superior surgical outcomes. Our passion to advance spine-care solutions is driven by clinical insights, sound research, and science-based design. DeGen Medical maintains the highest quality standards to provide reliable products and safeguard patient health.

A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=40928

For more information, please contact: Jessica Clark DeGen Medical, Inc. Phone: 877-240-7838 www.DeGenmedical.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Magna International's Impressive Quarterly Progress and Future Outlook

Updated Category News Views 285

Overview of Magna International's Second Quarter Results Magna International Inc. reported robust performance for the second quarter of 2025, showcasing resilience in the face of industry challenges. The company achieved $10.6 billion in sales, despite a 3% decline compared to the previous year, attributed mainly to lower light vehicle production in various markets....

Continue Reading
Mill Creek’s Desert Ridge Project Spurs Housing Growth

Updated Category News Views 19

Big Times for Desert Ridge with Modera City North Look alive, folks! There's movement on the horizon in Phoenix's Desert Ridge scene. Mill Creek Residential has kicked off the Modera City North project, aiming to inject 330 homes into this rapidly blossoming neighborhood. It's part of the City North master plan—spanning across 100 acres with two million square feet of...

Continue Reading
Stellantis Faces Lowest Italian Vehicle Production in Decades

Updated Category News Views 378

Stellantis and Its Production Challenges in Italy Stellantis (NYSE: STLA), the result of a major merger between iconic brands, is experiencing a notable decline in vehicle production within Italy. This setback is particularly concerning as it represents the lowest output levels this country has seen since 1956. Declining Production Figures Reported Recent data from union...

Continue Reading
Analyst Insights on Crocs Q3 Earnings and Future Trends

Updated Category News Views 242

Crocs Inc Earnings Analysis for Q3 BofA Securities analyst Christopher Nardone maintains a Buy rating on Crocs, Inc (NASDAQ: CROX) with an ambitious price target set at $179. This outlook highlights the optimism surrounding the company's financial prospects as it gears up to disclose its third-quarter results. Results Anticipation Investors eagerly await the announcement,...

Continue Reading
Opportunity for Investors Affected by Petco Securities Fraud

Updated Category News Views 239

Opportunity for Investors Affected by Petco Securities Fraud Investors who have experienced significant losses in Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) are presented with a crucial chance to engage in a securities fraud lawsuit. Faruqi & Faruqi, LLP, a respected name in securities litigation, is advocating for investors affected by these circumstances....

Continue Reading